Procedural Sedation Completed Phase 2 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0034835 (Procedural Sedation)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03799783The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural DisordersTreatment